Organisation paid for research Program year 2019 Source: CMS Open Payments

Stephenson Cancer Ctr

Neither a doctor nor a teaching hospital

Research payments

$969,800

40 payments

Through program year 2019, Stephenson Cancer Ctr is reported as receiving $969,800 in research payments, across 40 payments.

By program year

1 row
Year Kind Amount Payments
2019 Research $969,800 40

Breakdown

Who paid Research payments · program year 2019
  1. Boehringer Ingelheim International GmbH $883,380 35 payments
  2. TESARO, Inc. $86,420 5 payments
Studies the money was for Research payments · program year 2019
  1. BI754111 & BI754091/BI75411 combination $834,031 10 payments
  2. A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Niraparib Maintenance Treatment in Patients With Hrd-Positive Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy $86,420 5 payments
  3. BI 754091 first-in-man dose escalation $49,349 25 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record